LumiraDx (LumiraDx) Change In Inventory : $35.9 Mil (TTM As of Jun. 2023)

View and export this data going back to 2021. Start your Free Trial

What is LumiraDx Change In Inventory?

LumiraDx's change in inventory for the quarter that ended in Jun. 2023 was $5.5 Mil. It means LumiraDx's inventory declined by $5.5 Mil from Mar. 2023 to Jun. 2023 .

LumiraDx's change in inventory for the fiscal year that ended in Dec. 2022 was $-2.3 Mil. It means LumiraDx's inventory increased by $2.3 Mil from Dec. 2021 to Dec. 2022 .

LumiraDx's Total Inventories for the quarter that ended in Jun. 2023 was $86.0 Mil.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. LumiraDx's Days Inventory for the quarter that ended in Jun. 2023 was 259.53.

Inventory Turnover measures how fast the company turns over its inventory within a year. LumiraDx's Inventory Turnover for the quarter that ended in Jun. 2023 was 0.35.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. LumiraDx's Inventory-to-Revenue for the quarter that ended in Jun. 2023 was 4.18.

LumiraDx Change In Inventory Historical Data

The historical data trend for LumiraDx's Change In Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

LumiraDx Change In Inventory Chart

LumiraDx Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Change In Inventory

-8.39

-73.30

-66.87

-2.27

LumiraDx Quarterly Data
	Dec19	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23
Change In Inventory	Get a 7-Day Free Trial								-13.68	-2.27	32.29	0.41	5.49

LumiraDx Change In Inventory Calculation

Change In Inventory is the difference between last period's ending inventory and the current period's ending inventory.

Change In Inventory for the trailing twelve months (TTM) ended in Jun. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $35.9 Mil.

LumiraDx (OTCPK:LMDXF) Change In Inventory Explanation

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

LumiraDx's Days Inventory for the quarter that ended in is calculated as:

Days Inventory	=	Average Total Inventories	/	Cost of Goods Sold	*	Days in Period
	=	87.8975	/	30.905	*	365 / 4
	=	259.53

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

LumiraDx's Inventory Turnover for the quarter that ended in Jun. 2023 is calculated as

Inventory Turnover	=	Cost of Goods Sold	/	Average Total Inventories
	=	30.905	/	87.8975
	=	0.35

3. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

LumiraDx's Inventory to Revenue for the quarter that ended in Jun. 2023 is calculated as

Inventory-to-Revenue	=	Average Total Inventories	/	Revenue
	=	87.8975	/	21.004
	=	4.18

LumiraDx Change In Inventory Related Terms

Thank you for viewing the detailed overview of LumiraDx's Change In Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.

LumiraDx (LumiraDx) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » LumiraDx Ltd (OTCPK:LMDXF) » Definitions » Change In Inventory

Comparable Companies

Traded in Other Exchanges

N/A

Address

C/o Ocorian Trust (Cayman) Ltd, Windward 3, P.O. Box 1350, Regatta Office Park, Grand Cayman, CYM, KY1-1108

Website

https://www.lumiradx.com

LumiraDx Ltd is a next-generation point of care diagnostics company. It manufactures and commercializes an innovative diagnostic Platform that supports a broad menu of tests with lab comparable performance at the point of care. Geographical presence in United States, Italy, UK, Germany, Colombia, Sweden and Other countries. Majority revenue derives from U.S.